AGP Executive Report
Last update: 4 hours agoNational Cancer Program: Uzbekistan approved a WHO-backed overhaul aiming to lift five-year oncology survival from 35% to at least 45% by 2030, with 60% screening coverage and palliative care reaching 80%. Drug Access Financing: AstraZeneca proposed a cost-sharing model to help Uzbekistan procure modern medicines without overburdening the state budget. School Nutrition Push: Nestlé’s “Health Routes” program now reaches 12,000+ students nationwide, adding a hands-on “Food Laboratory” format focused on nutrition, hygiene, activity, and environment. Regulatory Updates: Uzbekistan set new ICH-aligned drug registration rules, including mandatory GMO and prion-related disclosures. Pharma Advertising Enforcement: Nika Farm was fined after a nasal spray ad used historical figures’ images in a way regulators said violated ethics and advertising norms. Workforce & Health Mobility: Uzbekistan and Sweden signed a migration and mobility partnership, with early focus on healthcare and caregiving labor pipelines plus simplified visa steps. Public Health Safety Note: A Caspian cobra sighting in eastern Uzbekistan sparked renewed interest in venom research for potential cancer treatments.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
